Close X
Tuesday, December 3, 2024
ADVT 
International

Indian-origin student shot dead by unknown men in US: Report

Darpan News Desk IANS, 30 May, 2023 10:30 AM
  • Indian-origin student shot dead by unknown men in US: Report

New York, May 30 (IANS) A 21 year-old Indian-origin student was shot dead by unidentified assailants in Philadelphia, a media report said.

Jude Chacko, hailing from Kerala's Kollam district, was gunned down while he was returning from work on Sunday (local time), Khaleej Times reported.

His parents migrated to the US more than 30 years ago.

Chacko, a student who also worked part-time, was attacked by two men during a robbery attempt, the report said citing police officials.

His funeral is likely to be held at a Malankara Catholic Church in Philadelphia on Saturday.

In April this year, Saiesh Veera, a 24-year-old student from Andhra Pradesh, was shot dead by unknown men at a fuel station in Ohio.

MORE International ARTICLES

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II